NSE · PPLPHARMA
Piramal Pharma Limited
Historical price visualisation is temporarily undergoing corporate data-licensing maintenance. Full interactive price and chart data will return following our upcoming authorized NSE/BSE data-feed deployment. Derived metrics (valuation ratios, market-cap rank), company financials, shareholding, corporate actions, and mutual-fund holdings remain available.
Market cap rank
#302
of 5,096 stocks
▲ 31W
Peak #301 · 27 Sep 2026
Piramal Pharma Limited is a largecap company in the Healthcare space and has a subdued return on equity, is seeing revenue slip, and has promoters holding 35%.
Market Cap
27,421.72 Cr
P/E Ratio
—
P/B Ratio
3.36
ROE
-3.99%
ROCE
2.30%
Dividend Yield
—
52W High
—
52W Low
—
Quarterly financials
| Metric | Q1 2026-27 | Q4 2025-26 | Q3 2025-26 | Q2 2025-26 |
|---|---|---|---|---|
| Revenue | 2,269.92 Cr | 2,751.77 Cr | 2,139.87 Cr | 2,043.72 Cr |
| Net Profit | -69.39 Cr | -8.82 Cr | -136.19 Cr | -99.22 Cr |
| EPS | -0.52 | -0.07 | -1.03 | -0.75 |
| Operating Profit | 61.06 Cr | 288.19 Cr | 26.23 Cr | 21.45 Cr |
Shareholding pattern
Promoter
34.80%
Public
64.72%
PUBLIC BREAKDOWN
FII
12.52%
DII
14.57%
MF (within DII)
13.18%
Individuals
15.63%
Mutual fund holdings
₹3,445.67
Cr total
92
Schemes
22
Fund Houses
₹3,445.67 Cr
Total Exposure
HDFC Mutual Fund₹1,712.32 Cr (49.7%)
Nippon India Mutual Fund₹445.93 Cr (12.9%)
Franklin Templeton Mutual Fund₹284.16 Cr (8.2%)
Canara Robeco Mutual Fund₹281.04 Cr (8.2%)
Bajaj Finserv Mutual Fund₹254.35 Cr (7.4%)
Others₹467.86 Cr (13.6%)
Recent corporate actions
| Ex-Date | Type | Details |
|---|---|---|
| 16 Jul 2025 | Dividend | Dividend - Re 0.14 Per Share |
| 12 Jul 2024 | Dividend | Dividend - Rs 0.11 Per Share |
| 02 Aug 2023 | Rights | Rights 5:46 @ Premium Rs 71/- |
Need this data in your app?
Full price history, technical indicators, and every field above via one REST API call.